We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
+13.99%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.33B
AUM Growth
+$796M
(+12%)
Cap. Flow
-$12M
Cap. Flow
% of AUM
-0.16%
Top 10 Holdings %
Top 10 Hldgs %
60.07%
Holding
377
New
123
Increased
61
Reduced
77
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$68.6M |
| 2 |
argenx
ARGX
|
+$55M |
| 3 |
Sanofi
SNY
|
+$50.7M |
| 4 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$50.5M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$48.6M |
| 2 |
Keurig Dr Pepper
KDP
|
+$45.5M |
| 3 |
Incyte
INCY
|
+$45.2M |
| 4 |
UnitedHealth
UNH
|
+$37.3M |
| 5 |
Campbell Soup
CPB
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.97% |
| 2 | Consumer Staples | 5.35% |
| 3 | Consumer Discretionary | 4.92% |
| 4 | Technology | 3.86% |
| 5 | Communication Services | 1.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Shopify
SHOP
$187B
| $496K | 0.01% |
+6,366
| New | +$407K |
|
202
Brookfield
BN
$109B
| $496K | 0.01% |
+18,533
| New | +$421K |
|
203
Microbot Medical
MBOT
$124M
| $492K | 0.01% |
+300,000
| New | +$399K |
|
204
MGM Resorts International
MGM
$11.4B
| $482K | 0.01% |
+10,778
| New | +$423K |
|
205
lululemon athletica
LULU
$14B
| $470K | 0.01% |
920
-22,012
| -96% | -$9.51M |
|
206
PRF Technologies Ltd
PRFX
$3.35M
| $468K | 0.01% |
+1,417
| New | +$429K |
|
|
SMAR
207
DELISTED
Smartsheet Inc.
SMAR
| $467K | 0.01% |
+9,763
| New | +$416K |
|
208
Duolingo
DUOL
$6.3B
| $442K | 0.01% |
+1,950
| New | +$379K |
|
209
Hormel Foods
HRL
$13.9B
| $419K | 0.01% |
+13,062
| New | +$426K |
|
210
Carter's
CRI
$1.47B
| $394K | 0.01% |
+5,258
| New | +$365K |
|
211
Las Vegas Sands
LVS
$29.7B
| $393K | 0.01% |
+7,989
| New | +$378K |
|
212
Enveric Biosciences
ENVB
$6.73M
| $355K | ﹤0.01% |
+1,517
| New | +$466K |
|
213
Insulet
PODD
$9.23B
| $352K | ﹤0.01% |
+1,624
| New | +$279K |
|
214
Mattel
MAT
$4.2B
| $346K | ﹤0.01% |
+18,351
| New | +$357K |
|
215
Alarm.com
ALRM
$2.76B
| $346K | ﹤0.01% |
+5,351
| New | +$307K |
|
|
CANF
216
Can-Fite BioPharma American Depositary Shares
CANF
$6.86M
| $340K | ﹤0.01% |
+7,718
| New | +$332K |
|
|
ASNS
217
DELISTED
ACTELIS NETWORKS INC
ASNS
| $337K | ﹤0.01% |
+30,100
| New | +$351K |
|
218
Cadrenal Therapeutics
CVKD
$6.99M
| $307K | ﹤0.01% |
27,619
-37,867
| -58% | -$300K |
|
219
Acushnet Holdings
GOLF
$6.04B
| $300K | ﹤0.01% |
4,754
-13,608
| -74% | -$765K |
|
|
ADIL
220
Adial Pharmaceuticals
ADIL
$8.86M
| $296K | ﹤0.01% |
+6,360
| New | +$349K |
|
221
United Rentals
URI
$72.3B
| $281K | ﹤0.01% |
490
-533
| -52% | -$251K |
|
222
NexGel Inc Warrant
NXGLW
$31.4K
| $270K | ﹤0.01% |
550,000
| – | – |
|
|
ADXN
223
Addex Therapeutics
ADXN
$7.2M
| $260K | ﹤0.01% |
43,000
+16,150
| +60% | +$101K |
|
|
APCXW
224
DELISTED
AppTech Payments Corp Warrant
APCXW
| $250K | ﹤0.01% |
715,000
| – | – |
|
225
Okta
OKTA
$25.6B
| $243K | ﹤0.01% |
+2,682
| New | +$205K |
|
Similar funds
CRC
RMDI
F
EW
O
DSC
ACM
PI
Armistice Capital's Q4 2023 Portfolio in Review
As of Q4 2023, Armistice Capital held 377 positions worth $7.33B, up 12% from $6.53B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Armistice Capital's Q4 2023 filing shows 123 new, 61 increased, 77 reduced and 82 closed positions. Its largest new stake was Sanofi: 1,036,000 shares worth $51.5M. The largest sale was Mirati Therapeutics, Inc. Common Stock, an estimated $48.6M.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 34% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
- Armistice Capital's largest Q4 2023 buy was Sanofi: 1,036,000 shares worth $51.5M.
- Armistice Capital added most to GSK in Q4 2023, an estimated $68.6M increase.
- Armistice Capital's biggest Q4 2023 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $48.6M.
- Armistice Capital fully exited Keurig Dr Pepper in Q4 2023, selling an estimated $45.5M.
- Armistice Capital's ten largest holdings make up 60% of its $7.33B portfolio in Q4 2023.
- Armistice Capital opened 123 new positions and closed 82 in Q4 2023.
- Armistice Capital's portfolio value rose 12% quarter-over-quarter to $7.33B.
Based on Armistice Capital's 13F filing for Q4 2023, filed 13 Feb 2024.